News

Hurry and secure your place this weekend We invite all primary care professionals to New Zealand’s premier professional development event for general practice and primary care. Event Overview: 📅 March 2026 21-22 Due Drop Events Centre, Manukau Programme highlights : Hear from leading experts and our partners the Royal NZ College of GPs, the Royal NZ College of Urgent Care, and Allevia Hospitals - with a line-up that blends essential updates, fresh perspectives, and practice-changing...

New medicine supply notices Flumetasone pivalate (Locorten-Vioform) ear drops (Pharmacode 259799) There will be an out of stock until at least August 2026. The alternatives are Kenacomb (Pharmcode: 253634) and Sofradex (a part charge applies to Sofradex) (Pharmacode: 208728). Sodium Fusidate [fusidic acid] (Foban) Oint 2% (Pharmacode 2556189) The ointment may go out of stock. There is ample supply of the cream (Pharmacode: 2556170) to use as an alternative. Updated medicine supply notices...

The Misuse of Drugs (Medicinal Cannabis) Regulations 2019 (the Regulations) set the minimum quality standard that medicinal cannabis products and ingredients must meet before they can be supplied in New Zealand. Importers, manufacturers, and suppliers must apply for assessment and provide evidence to the Medicinal Cannabis Agency to verify that their products meet the minimum quality standard. Beacon Medical GSC THC20 CBD≤1 has been verified as meeting the minimum quality standard. Beacon...

Nurse Practitioner – Full or Part Time Residential Eldercare Services   🌟 Join Our Exceptional Team as a Nurse Practitioner! 🌟 Are you passionate about providing the highest standard of care to the elderly? Do you thrive in a collaborative and supportive work environment? We have an exciting job opportunity for Nurse Practitioners to join our unique totally mobile general practice dedicated to eldercare. At Residential Eldercare Services, we believe in fostering a dynamic and fulfilling...

From 1 July 2026, Pharmac will take over responsibility for funding medicines used in ambulances. This consultation seeks feedback on changes to the Pharmaceutical Schedule which supports this decision. Bringing ambulance medicines into the Pharmaceutical Schedule will help to ensure a more coordinated approach to funding and procurement decisions for emergency medicines, whether they are used in hospitals, ambulances or by PRIME providers. Under this proposal, we would also fund tenecteplase...

We have made the decision to widen access to brentuximab vedotin for systemic anaplastic large cell lymphoma from 1 April 2026 .  We expect this will improve the lives of around 12-13 people in New Zealand per year.Thank you to all those who provided feedback in response to the consultation, your feedback is appreciated. You can find more information on this decision on the Pharmac website including our responses to key points raised by consultees. Decision to widen access to brentuximab...